Validation of a New Three-Item Self-Report Measure for Medication Adherence

AIDS and Behavior

Volumn 20, Issue 11, 2016, Pages 2700-2708

  Wilson, Ira B ^a   Lee, Yoojin ^a   Michaud, Joanne ^a   Fowler, Floyd J ^b   Rogers, William H ^c  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

Highly active antiretroviral therapy; HIV; Medication adherence; Patient compliance; Self report

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; COMBINATION DRUG THERAPY; COMPARATIVE STUDY; DRUG MONITORING; ELECTRONIC HEALTH RECORD; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; PROCEDURES; PSYCHOLOGY; PSYCHOMETRY; QUESTIONNAIRE; SELF REPORT; STATISTICS AND NUMERICAL DATA; VALIDATION STUDY;

ADULT; ANTI-HIV AGENTS; DRUG MONITORING; DRUG THERAPY, COMBINATION; ELECTRONIC HEALTH RECORDS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PSYCHOMETRICS; SELF REPORT; SURVEYS AND QUESTIONNAIRES;

EID: 84964344256     PISSN: 10907165     EISSN: 15733254     Source Type: Journal    
DOI: 10.1007/s10461-016-1406-x     Document Type: Article

References (33)

1. Rand CS. “I took the medicine like you told me, Doctor”: self-reports of adherence with medical regimens. In: Stone AA, Turkkan JS, Bachrach CA, Jobe JB, Kurtzman HS, Cain VS, editors. The science of self-report: implications for research and practice, vol. 1. Mahwah: Lawrence Erlbaum Associates; 2000. p. 257–76.
2. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–97.
3. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50(1):105–16.
4. Demonceau J, Ruppar T, Kristanto P, et al. Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic literature review and meta-analysis. Drugs. 2013;73(6):545–62.
5. Kalichman SC, Amaral CM, Cherry C, et al. Monitoring medication adherence by unannounced pill counts conducted by telephone: reliability and criterion-related validity. HIV Clin Trials. 2008;9(5):298–308.
6. Wilson IB, Fowler FJ Jr, Cosenza CA, et al. Cognitive and field testing of a new set of medication adherence self-report items for HIV care. AIDS Behav. 2013;18(12):2349–58.
7. Fowler FJ, Lloyd SJ, Cosenza CA, Wilson IB. Coding cognitive interviews: an approach to enhancing the value of cognitive testing for survey question evaluation. Field Methods 2014;1525822X14549921.
8. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74.
9. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999;282(18):1737–44.
10. Saunders JB, Aasland OG, Babor TF, De la Fuente JR, Grant M. Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction. 1993;88(6):791–804.
11. Pence BW, Gaynes BN, Whetten K, Eron JJ Jr, Ryder RW, Miller WC. Validation of a brief screening instrument for substance abuse and mental illness in HIV-positive patients. J Acquir Immun Defic Syndr. 2005;40(4):434–44.
12. Genberg BL, Wilson IB, Bangsberg DR, et al. Patterns of antiretroviral therapy adherence and impact on HIV RNA among patients in North America. AIDS. 2012;26(11):1415–23.
13. Genberg BL, Lee Y, Rogers WH, Willey C, Wilson IB. Stages of change for adherence to antiretroviral medications. AIDS Patient Care STDS. 2013;27(10):567–72.
14. Genberg BL, Lee Y, Rogers WH, Wilson IB. Four types of barriers to adherence of antiretroviral therapy are associated with decreased adherence over time. AIDS Behav. 2015;19(1):85–92.
15. Gaito J. Measurement scales and statistics: resurgence of an old misconception. Psychol Bull. 1980;87(3):564–7.
16. Townsend JT, Hu GG, Evans RJ. Modeling feature perception in brief displays with evidence for positive interdependencies. Percept Psychophys. 1984;36(1):35–49.
17. Nunnally JC, Bernstein IH. Psychometric Theory. New York: McGraw-Hill, Inc.; 1994.
18. Thirumurthy H, Siripong N, Vreeman RC, et al. Differences between self-reported and electronically monitored adherence among patients receiving antiretroviral therapy in a resource-limited setting. AIDS. 2012;26(18):2399–403.
19. Shi LZ, Liu JN, Koleva Y, Fonseca V, Kalsekar A, Pawaskar M. Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices. Pharmacoeconomics. 2010;28(12):1097–107.
20. Shi L, Liu J, Fonseca V, Walker P, Kalsekar A, Pawaskar M. Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis. Health Qual Life Outcomes. 2010;8(1):99.
21. Amico KR, Marcus JL, McMahan V, et al. Study product adherence measurement in the iPrEx placebo-controlled trial: concordance with drug detection. J Acquir Immun Defic Syndr. 2014;66(5):530–7.
22. Wilson IB, Carter AE, Berg KM. Improving the self-report of HIV antiretroviral medication adherence: is the glass half full or half empty? CurrHIV/AIDS Rep. 2009;6(4):177–86.
23. Blair E, Burton S. Cognitive-processes used by survey respondents to answer behavioral frequency questions. J Consum Res. 1987;14(2):280–8.
24. Menon G. The effects of accessibility of information in memory on judgments of behavioral frequencies. J Consum Res. 1993;20(3):431–40.
25. Harrell FE, Lee KL, Mark DB. Tutorial in biostatistics multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361–87.
26. Wendel CS, Mohler MJ, Kroesen K, Ampel NM, Gifford AL, Coons SJ. Barriers to use of electronic adherence monitoring in an HIV clinic. Ann Pharmacother. 2001;35(9):1010–5.
27. Wilson IB, Tchetgen E, Spiegelman D. Patterns of adherence with antiretroviral medications: an examination of between-medication differences. J Acquir Immun Defic Syndr. 2001;28(3):259–63.
28. McNabb JJ, Nicolau DP, Stoner JA, Ross J. Patterns of adherence to antiretroviral medications: the value of electronic monitoring. AIDS. 2003;17(12):1763–7.
29. Gardner EM, Burman WJ, Maravi ME, Davidson AJ. Selective drug taking during combination antiretroviral therapy in an unselected clinic population. J Acquir Immun Defic Syndr. 2005;40(3):294–300.
30. Deschamps AE, De Geest S, Vandamme AM, Bobbaers H, Peetermans WE, van Wijngaerden E. Diagnostic value of different adherence measures using electronic monitoring and virologic failure as reference standards. AIDS Patient Care STDS. 2008;22(9):735–43.
31. Osterberg L, Urquhart J, Blaschke T. Understanding forgiveness: minding and mining the gaps between pharmacokinetics and therapeutics. Clin Pharmacol Ther. 2010;88(4):457–9.
32. Gulick RM. Adherence to antiretroviral therapy: how much is enough? Clin Infect Dis. 2006;43(7):943–4.
33. Kravitz RL, Melnikow J. Medical adherence research: time for a change in direction? Med Care. 2004;42(3):197–9.